• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    3. GE Healthcare

    ...

    Related CONTENT
    • Medical Devices Market to Top $671.49 Billion by 2027
    • GE Healthcare Reveals AMX Navigate Portable X-Ray System
    • GE Healthcare, AWS Partner to Transform Care Delivery
    • Disinfectant Resistance is Crucial in Medtech Material Selection
    • Substantial Growth Predicted for Global Ventilators Market
    07.30.19
    AT A GLANCE
    Rank: #3 (Last year: #3)
    $19.78 Billion ($122B total)
    Prior Fiscal: $19.02 Billion
    Percentage Change: +4%
    No. of Employees: 53,800 (283,000 total)
    Global Headquarters: Chicago, Ill.

    KEY EXECUTIVES
    H. Lawrence Culp, Jr. Chairman and CEO, GE
    Jamie S. Miller Sr. VP and CFO, GE
    Kieran P. Murphy, Sr. VP, GE; President and CEO, GE Healthcare
    Monish Patolawala, CFO, GE Healthcare
    Amit Phadnis, Chief Digital Officer, GE Healthcare
    Jan Makela, President and CEO, Global Services, GE Healthcare
    Thomas Westrick, VP and Chief Quality Officer, GE Healthcare
    Greg Gibbons, Chief Communications Officer, GE Healthcare
    Terri Bresenham, Chief Innovation Officer, GE Healthcare
    Ehren Powell, Chief Information Officer, GE Healthcare
    Katya Kruglova, VP, Human Resources, GE Healthcare
    Michael McAlevey, VP, General Counsel and Business Development, GE Healthcare
    James W. Borzi, VP and Chief Supply Chain Officer, GE Healthcare
    Anders Wold, President and CEO, GE Healthcare Clinical Care Solutions
    Tom McGuinness, President and CEO, GE Healthcare Imaging
    Emmanuel Ligner, President and CEO, GE Healthcare Life Sciences
    Laurent Dubois, CEO, GE Healthcare Partners
    Lee Cooper, President and CEO, GE Healthcare U.S. and Canada
    Farid Fezoua, President and CEO, GE Healthcare Africa
    Luiz Verzegnassi, President and CEO, GE Healthcare Latin America
    Rachel Duan, President and CEO, GE Healthcare China
    Soichiro Tada, President and CEO, GE Healthcare Japan
    Nalinikanth (Nal) Gollagunta, President and CEO, GE Healthcare India and South Asia
    Elie Chaillot, President and CEO, GE Healthcare Eastern Growth Markets
    Catherine Estrampes, President and CEO, GE Healthcare Europe

    Some had thought it possible that by the time this report on the GE Healthcare unit was being read, the firm would have been spun out as its own, standalone company. As it turns out, that timeline may have been anticipated a little prematurely. Due to several factors, GE Healthcare—to date—still remains a part of its conglomerate parent company, although no longer in its entirety as it was constructed at the start of 2018.

    In late June 2018, it was announced by then-GE CEO John Flannery that GE Healthcare would be launched from the mothership to fend for itself as an independent entity. The unit’s split made sense from the standpoint—it was financially strong, provided an array of products, and would potentially thrive as a business with a single focus, catering exclusively to the technology needs of medicine. At the same time, GE would generate cash from the disposition of 20 percent of its interest in the firm to help reduce debt, while providing the remaining 80 percent to the parent company’s shareholders.

    In a company statement, Kieran Murphy, president and CEO of GE Healthcare, who would have remained in the position to lead the new spun-out firm, said, “GE Healthcare’s vision is to drive more individualized, precise, and effective patient outcomes. As an independent global healthcare business, we will have greater flexibility to pursue future growth opportunities, react quickly to changes in the industry, and invest in innovation. We will build on strong customer demand for integrated precision health solutions and great technology with digital and analytics capabilities as we enter our next chapter.”

    Or, at least, that was the plan. Unfortunately, as is said of best laid plans…

    On Oct. 1, 2018, GE announced it had instead decided to spin out Flannery and replaced him with H. Lawrence Culp Jr., former CEO and president of Danaher. Culp had held his former role from 2001 to 2014. During his tenure, he led a number of strategic acquisitions and divestitures—perhaps the experience GE’s board valued given the firm’s intent to slim itself down. Further, according to the statement issued by GE at the time of the personnel change, while at Danaher, Culp saw the company’s market capitalization and revenues grow five-fold. Given the struggles the firm had been experiencing, GE certainly needed someone at the helm who had a proven history of positive financial experience.

    The CEO swap generated immediate speculation on whether or not the GE Healthcare standalone launch would still take place. Jim Corridore, a research equity analyst at CFRA, told CNBC that Culp may not have the same plan for the healthcare segment. Meanwhile, corporate spokeswoman for GE, Jennifer Fox, assured, “Today’s news does not change what’s happening at GE Healthcare and it plans to continue working toward separation from GE.”

    Not so fast, Fox.

    By mid-November, plans were in a state of flux once again, Culp revealed in a discussion with CNBC’s David Faber. The CEO told the financial journalist and market news analyst that the Healthcare unit was a “tremendous” franchise and the parent company could “preserve our tax-free spin status while selling up to 49.9 percent” of the segment, significantly more than earlier statements, which put the percentage around 20. During the same interview, Culp revealed his former employer, Danaher, would “love” to own GE Healthcare’s Life Sciences business.


    ANALYST INSIGHTS: The good news for GE Healthcare is that it continues to consistently move forward as a profitable business unit within GE. The bad news for GE Healthcare is that it continues to be a part of GE. GE continues to debate spinning off GE Healthcare as a separate business—via IPO. If this happens, it will be a positive for GE Healthcare as it will unleash the opportunity for strategic investments for its future growth. Otherwise, GE Healthcare will be challenged to keep up with its competitors for the long-term.

    —Dave Sheppard, Co-Founder and Managing Director, MedWorld Advisors



    Still further fueling the rabid speculation over what the firm was up to, in the latter half of December, it was revealed GE had filed a “confidential IPO” for its healthcare unit. While the public filing was expected for the following (2019) spring, Bloomberg Intelligence analyst Karen Ubelhart estimated the enterprise value of the spinoff at $65 billion to $70 billion.

    Finally, in late February 2019, as if in an effort to put to rest all the gossip and ballyhoo regarding the future of the Healthcare business unit, GE announced it was selling its biopharmaceutical business to Danaher. While the deal was likely not a surprise to anyone who had been keeping tabs on the comments made by Culp in the year prior, the transaction immediately called into question the further divestiture of any additional aspects of the medical technology segment. Culp, however, addressed any uncertainty regarding the public offering by stating the IPO was now “unlikely.”

    The $21.4 billion deal with Danaher represented the sale of 15 percent of GE Healthcare’s business. The unit manufactures equipment and special resins that help pharma companies discover and mass produce biopharmaceuticals intended to fight autoimmune diseases. It also aids vaccine developers and researchers explore immunotherapy, according to GE.

    Not included in the transaction was the Pharmaceutical Diagnostics unit, which develops contrast media for radiologists. Retaining that segment of the Life Sciences business makes sense since the media is used in combination with GE’s computed tomography, positron emission tomography, and magnetic resonance scanners.

    While the spinout of GE Healthcare from the parent firm would have certainly been the biggest M&A move for the business in 2018, it certainly wasn’t the only one making headlines during the year. In April, the healthcare business sold its IT unit to Veritas Capital for $1.05 billion. The assets comprising the IT segment consisted of Enterprise Financial Management (Revenue-Cycle, Centricity Business), Ambulatory Care Management (Centricity Practice Solution), and Workforce Management (formerly API Healthcare).

    In the news release announcing the sale, which closed two months later in June, Murphy said, “We’re confident this business will flourish under Veritas Capital, while GE Healthcare will continue to significantly invest in core digital solutions, such as smart diagnostics, connected devices, AI, and enterprise imaging, that will drive precision health for our customers. We will continue to lead in data analytics, command centers, advanced visualization, and image management tools to create better customer and patient outcomes.”

    Earning two spots on GE Healthcare’s divestiture dance card, cancer diagnostics firm Inspirata waltzed away with both Omnyx in late January and Caradigm in mid-June; neither sale’s financial details were disclosed. Omnyx provides a digital platform to enable pathologists worldwide to work and collaborate to improve cancer diagnostics. Meanwhile, Caradigm offers a variety of population health solutions, including services based on data control, analytics, and care coordination and patient engagement.

    Perhaps in another move to rid itself of assets deemed to be outside its dedicated focus on specific therapeutic segments, during the last quarter of 2018, GE Healthcare sold off all shares of NeoGenomics, a genetics-testing firm. It first sold shares in November valued at almost $70 million and followed that up with a final sale of all remaining shares in December—a move that returned $130 million to the company’s coffers.

    That financial windfall was in addition to the $19.78 billion in revenues GE Healthcare saw in 2018—up 4 percent over the prior year—which represented a profit of $3.7 billion for the parent firm. The clear majority of that revenue was generated by the organization’s Healthcare Systems sub-segment, which contributed $14.9 billion in 2018, compared to $14.5 billion a year earlier. The other sub-segment that comprises GE Healthcare is the Life Sciences portion, which put $4.9 billion toward the revenue total (up from $4.6 billion in 2017). Given the divestiture of a significant piece of the Life Sciences unit to Danaher, this number will most certainly decrease in 2019.

    When looking at GE Healthcare’s worldwide business, the figures reveal while the U.S. is the largest revenue generator compared to other regions, when compared to the total for the rest of the world, it represents the minority portion. Non-U.S. revenues accounted for 57 percent of the company’s overall figure, which translates to $11.2 billion (56 percent in 2017; $10.6 billion). To that number, Asia contributes the greatest portion at $5.2 billion, followed closely by Europe at $4.1 billion (compared to $4.9 and $3.9 billion respectively in 2017). The Americas ($1.0 billion) and Middle East/Africa ($0.9 billion) round out the 57 percent, each flat versus 2017. In contrast, the U.S. has a revenue figure of $8.6 billion, which was a slight increase over year prior ($8.4 billion).

    Looking ahead, GE Healthcare is positioning itself rather well to serve the emerging trends in the medical treatment space—that is, the implementation of analytics and artificial intelligence (AI) in the clinical space. To that end, the firm developed a next-generation intelligence platform called Edison. The intent of this initiative is to enable smart product and new applications to be built on the platform. In doing so, Edison helps to accelerate the development and adoption of AI technology for the medical space. The solution will not only allow GE Healthcare to develop new “smart” technologies—clinical partners can use Edison to develop algorithms. Further, technology firms can team with GE Healthcare to introduce data processing advancements to medical devices and applications.

    “There’s a lot of hidden meaning in the deep data, but it takes a significant sophistication to extract the value,” said Dr. Rachael Callcut, associate professor of surgery at UCSF, a surgeon at UCSF Health, director of data science for the Center for Digital Health Innovation, and a partner in the development of Critical Care Suite (one of several new healthcare solutions developed on Edison). “AI gives us an opportunity to see patterns that we don’t see and change the way we care for patients, which can ultimately improve outcomes.”

    The aforementioned Critical Care Suite is designed to identify cases with the critical condition of pneumothorax at the point of care to enable prioritization of image review, according to an announcement made in late November 2018 regarding several new offerings all developed with the aid of Edison. AIRx, an AI-based, automated workflow tool for MRI brain scanning designed to increase consistency and productivity, was another. In addition, CT Smart Subscription provides continuous access to the latest CT software, extending the lifecycle of a device and making it more valuable over time. Rounding out the announced tools was an Automated Lesion Segmentation solution that helps eliminate the need for the user to measure lesions manually, by segmenting an identified breast, thyroid, or liver lesion and automatically providing a trace of the lesion and corresponding area.

    “Edison provides clinicians with an integrated digital platform, combining diverse data sets from across modalities, vendors, healthcare networks and life sciences settings,” said GE Healthcare’s Murphy. “Applications built on Edison will include the latest data processing technologies to enable clinicians to make faster, more informed decisions to improve patient outcomes.”

    Further illustrating its data/IT-centric focus, GE announced near the start of 2018 that it was teaming with Roche on a digital diagnostics platform for oncology and critical care treatment. The goal of the joint venture is to develop an industry-first digital platform to support clinical decisions by providing workflow solutions and apps. The system would leverage advanced analytics to enable the integration and analysis of in-vivo and in-vitro data, patient records, medical best practices, real time monitoring, and the latest research outcomes.

    “This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree. We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients, and the healthcare industry,” said Murphy.

    Perhaps recognizing the leadership position GE had taken in the implementation of AI in the care space, NHS enlisted the company to build a centralized healthcare command center. The facility will be located at the Bradford Royal Infirmary, which is a teaching hospital in the U.K. A first-of-its-kind location in Europe, the center will utilize AI to transform how care is delivered and organized across the 800-bed hospital. Specifically, it will help to reduce unnecessary time spent in the hospital after a patient is medically ready to leave; increase the proportion of patients who arrive and are admitted, transferred, or discharged from A&E (i.e., the emergency department) within four hours; and help ensure patients are always treated in the wards best suited to manage their care. The center will be based on similar facilities in the U.S. and Canada, including The Johns Hopkins Hospital in Baltimore and Humber River Hospital in Toronto.

    Catering to another rapidly growing trend in healthcare, the firm teamed with the Department of Veterans Affairs (VA) to accelerate the use of 3D printing in patient care. Specifically, the effort is seeking to reduce the time it takes for radiologists to create 3D-printed models and prosthetics from hours to minutes. The research agreement sees GE Healthcare providing software and work stations, while the VA will offer input on its use of the technology; the VA was previously using 3D software not intended for medical use.

    “We are delighted to partner with the Veterans Administration to accelerate 3D printing in healthcare,” Terri Bresenham, chief innovation officer for GE Healthcare, said in a statement announcing the endeavor. “This partnership will result in significant innovation for the growing application of additive manufacturing in medicine while advancing GE Healthcare toward its mission to improve patient outcomes and enable precision healthcare.”
    Related Searches
    • led
    • Manufacturing
    • cancer
    • first
    Suggested For You
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    GE Healthcare Reveals AMX Navigate Portable X-Ray System GE Healthcare Reveals AMX Navigate Portable X-Ray System
    GE Healthcare, AWS Partner to Transform Care Delivery GE Healthcare, AWS Partner to Transform Care Delivery
    Disinfectant Resistance is Crucial in Medtech Material Selection Disinfectant Resistance is Crucial in Medtech Material Selection
    Substantial Growth Predicted for Global Ventilators Market Substantial Growth Predicted for Global Ventilators Market
    GE Healthcare, ACC Team Up to Advance AI in Cardiac Care GE Healthcare, ACC Team Up to Advance AI in Cardiac Care
    GE Healthcare Buys Zionexa, a Breast Cancer Dx Startup GE Healthcare Buys Zionexa, a Breast Cancer Dx Startup
    PENTAX Appoints Former Philips VP Ojas A. Buch as President, Americas PENTAX Appoints Former Philips VP Ojas A. Buch as President, Americas
    Cardiovascular Device Market Expands to Tackle Higher Disease Burden Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    FDA OKs GE Healthcare FDA OKs GE Healthcare's New 3D Surgical Imaging System
    GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound
    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    Refurbished Medical Imaging Equipment Market to be Worth $21.14 Billion By 2027 Refurbished Medical Imaging Equipment Market to be Worth $21.14 Billion By 2027
    SmartBreast Corp. Acquires Discover NM750b from GE Healthcare SmartBreast Corp. Acquires Discover NM750b from GE Healthcare
    Medtech Veteran Joins VivaLNK Board Medtech Veteran Joins VivaLNK Board

    Related Breaking News

    • Medical Devices Market to Top $671.49 Billion by 2027

      Medical Devices Market to Top $671.49 Billion by 2027

      Wearables and rising cases of chronic diseases will help fuel growth, industry data predicts.
      Precedence Research 09.16.21

    • Diagnostics
      GE Healthcare Reveals AMX Navigate Portable X-Ray System

      GE Healthcare Reveals AMX Navigate Portable X-Ray System

      Helps address technologist stress and strain and improve efficiency.
      Business Wire 09.01.21

    • Diagnostics | Digital Health | Software & IT
      GE Healthcare, AWS Partner to Transform Care Delivery

      GE Healthcare, AWS Partner to Transform Care Delivery

      AI-based imaging applications and Edison Health Services platform on AWS.
      Business Wire 08.09.21


    • Materials
      Disinfectant Resistance is Crucial in Medtech Material Selection

      Disinfectant Resistance is Crucial in Medtech Material Selection

      Understanding the kinds of materials that stand up to healthcare-grade disinfectants can help ensure device longevity.
      Michael Barbella, Managing Editor 07.27.21

    • Substantial Growth Predicted for Global Ventilators Market

      Substantial Growth Predicted for Global Ventilators Market

      Aging population, increasing infectious disease rates to drive growth through 2026.
      Market Study Report 07.13.21

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login